DS-8201 (trastuzumab deruxtecan)

trastuzumab deruxtecan · Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DS-8201 (trastuzumab deruxtecan), covering 2025-04-25 to 2025-04-25. Get the full timeline:

Most recent: Clinical Trial Update: A ReaL World Study of DS-8201